EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Barrier Therapeutics, Inc. (the
"Company") on Form 10-Q for the quarterly period ended June 30, 2004 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Anne M. VanLent, Executive Vice President, Chief Financial Officer and
Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, based on my
knowledge, thaT:

(1)   The Report fully complies with the requirements of section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the Company.

ANNE M. VANLENT
- ---------------------------------
Anne M. VanLent
Executive Vice President, Chief Financial Officer and Treasurer

August 11, 2004